Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV Agents

Targeting the fusion (F) protein has been recognized as a fruitful strategy for the development of anti-RSV agents. Despite the considerable efforts so far put into the development of RSV F protein inhibitors, the discovery of adequate therapeutics for the treatment of RSV infections is still awaiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Cichero, Elena, Calautti, Alessio, Francesconi, Valeria, Tonelli, Michele, Schenone, Silvia, Fossa, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707824/
https://www.ncbi.nlm.nih.gov/pubmed/34959708
http://dx.doi.org/10.3390/ph14121307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707824/
https://www.ncbi.nlm.nih.gov/pubmed/34959708
http://dx.doi.org/10.3390/ph14121307

Ejemplares similares